Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Struct Dyn ; 10(6): 064302, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38058995

ABSTRACT

The ability to resolve the dynamics of matter on its native temporal and spatial scales constitutes a key challenge and convergent theme across chemistry, biology, and materials science. The last couple of decades have witnessed ultrafast electron diffraction (UED) emerge as one of the forefront techniques with the sensitivity to resolve atomic motions. Increasingly sophisticated UED instruments are being developed that are aimed at increasing the beam brightness in order to observe structural signatures, but so far they have been limited to low average current beams. Here, we present the technical design and capabilities of the HiRES (High Repetition-rate Electron Scattering) instrument, which blends relativistic electrons and high repetition rates to achieve orders of magnitude improvement in average beam current compared to the existing state-of-the-art instruments. The setup utilizes a novel electron source to deliver femtosecond duration electron pulses at up to MHz repetition rates for UED experiments. Instrument response function of sub-500 fs is demonstrated with < 100 fs time resolution targeted in future. We provide example cases of diffraction measurements on solid-state and gas-phase samples, including both micro- and nanodiffraction (featuring 100 nm beam size) modes, which showcase the potential of the instrument for novel UED experiments.

2.
BMC Psychiatry ; 23(1): 444, 2023 06 16.
Article in English | MEDLINE | ID: mdl-37328751

ABSTRACT

BACKGROUND: Psychosis treatment guidelines recommend cognitive behaviour therapy (CBT) and family intervention (FI), for all patients with first episode psychosis (FEP), though guidance borrows heavily from literature in adults from high income countries. To our knowledge, there are few randomized controlled trials (RCTs) examining the comparative effect of these commonly endorsed psychosocial interventions in individuals with early psychosis from high-income countries and no such trials from low and middle-income countries (LMICs). The present study aims to confirm the clinical-efficacy and cost-effectiveness of delivering culturally adapted CBT (CaCBT) and culturally adapted FI (CulFI) to individuals with FEP in Pakistan. METHOD: A multi-centre, three-arm RCT of CaCBT, CulFI, and treatment as usual (TAU) for individuals with FEP (n = 390), recruited from major centres across Pakistan. Reducing overall symptoms of FEP will be the primary outcome. Additional aims will include improving patient and carer outcomes and estimating the economic impact of delivering culturally appropriate psychosocial interventions in low-resource settings. This trial will assess the clinical-efficacy and cost-effectiveness of CaCBT and CulFI compared with TAU in improving patient (positive and negative symptoms of psychosis, general psychopathology, depressive symptoms, quality of life, cognition, general functioning, and insight) and carer related outcomes (carer experience, wellbeing, illness attitudes and symptoms of depression and anxiety). CONCLUSIONS: A successful trial may inform the rapid scale up of these interventions not only in Pakistan but other low-resource settings, to improve clinical outcomes, social and occupational functioning, and quality of life in South Asian and other minority groups with FEP. TRIAL REGISTRATION: NCT05814913.


Subject(s)
Cognitive Behavioral Therapy , Psychotic Disorders , Adult , Humans , Psychosocial Intervention , Psychotic Disorders/therapy , Cognitive Behavioral Therapy/methods , Treatment Outcome , Anxiety , Randomized Controlled Trials as Topic
3.
J Urol ; 210(2): 257-271, 2023 08.
Article in English | MEDLINE | ID: mdl-37126232

ABSTRACT

PURPOSE: Latent grade group ≥2 prostate cancer can impact the performance of active surveillance protocols. To date, molecular biomarkers for active surveillance have relied solely on RNA or protein. We trained and independently validated multimodal (mRNA abundance, DNA methylation, and/or DNA copy number) biomarkers that more accurately separate grade group 1 from grade group ≥2 cancers. MATERIALS AND METHODS: Low- and intermediate-risk prostate cancer patients were assigned to training (n=333) and validation (n=202) cohorts. We profiled the abundance of 342 mRNAs, 100 DNA copy number alteration loci, and 14 hypermethylation sites at 2 locations per tumor. Using the training cohort with cross-validation, we evaluated methods for training classifiers of pathological grade group ≥2 in centrally reviewed radical prostatectomies. We trained 2 distinct classifiers, PRONTO-e and PRONTO-m, and validated them in an independent radical prostatectomy cohort. RESULTS: PRONTO-e comprises 353 mRNA and copy number alteration features. PRONTO-m includes 94 clinical, mRNAs, copy number alterations, and methylation features at 14 and 12 loci, respectively. In independent validation, PRONTO-e and PRONTO-m predicted grade group ≥2 with respective true-positive rates of 0.81 and 0.76, and false-positive rates of 0.43 and 0.26. Both classifiers were resistant to sampling error and identified more upgrading cases than a well-validated presurgical risk calculator, CAPRA (Cancer of the Prostate Risk Assessment; P < .001). CONCLUSIONS: Two grade group classifiers with superior accuracy were developed by incorporating RNA and DNA features and validated in an independent cohort. Upon further validation in biopsy samples, classifiers with these performance characteristics could refine selection of men for active surveillance, extending their treatment-free survival and intervals between surveillance.


Subject(s)
Prostatic Neoplasms , Watchful Waiting , Male , Humans , Prostatic Neoplasms/genetics , Prostatic Neoplasms/surgery , Prostatic Neoplasms/pathology , Neoplasm Grading , Prostatectomy , Prostate-Specific Antigen , Biomarkers , RNA , RNA, Messenger
4.
Mymensingh Med J ; 32(1): 10-17, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36594293

ABSTRACT

Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. It is common in all ages and the prevalence is increasing in most countries, especially among children as because of urbanization. Multiple therapeutic modalities are available for management of acute asthma. The commonly used formulation is Racemic Salbutamol which contains equal amounts of both R and S isomers. Levosalbutamol contains only R isomer. The aim of the study was to compare the efficacy of levosalbutamol and racemic salbutamol for the treatment of acute exacerbation of asthma in children (5 to 15 years). A randomized double blind clinical trial was conducted in the Department of Paediatrics, Sylhet MAG Osmani Medical College Hospital, Sylhet, Bangladesh from October 2013 to March 2014. In this study randomization was done in two groups. Group A received nebulized levosalbutamol (LEV) and Group B received nebulized racemic salbutamol (RAC). The study parameters were respiratory rate (RR), heart rate (HR), oxygen saturation in room air (SpO2), PEFR, asthma score and serum K+ level. The results of treatment outcome were compared between two groups. After treatment the respiratory rate was 24.4±5.6 per minute versus 27.6±5.3 per minute (p<0.05); heart rate was 115.5±16.4 per minute versus 124.5±12.0 per minute (p<0.05); SpO2 was 97.2±1.8% vs 95.0±1.6% (p<0.05); PEFR was found 159.6±30.7L/min versus 143.8±27.1L/min (p<0.05) in the LEV and RAC group respectively. LEV is more effective than RAC in respect to significant improvement of asthma score. Regarding adverse events racemic salbutamol causes significant tachycardia. The study concluded that nebulized levosalbutamol is superior to racemic salbutamol in children in the treatment of acute exacerbation of asthma.


Subject(s)
Albuterol , Asthma , Adult , Humans , Child , Albuterol/therapeutic use , Albuterol/adverse effects , Bangladesh , Asthma/drug therapy , Levalbuterol/therapeutic use , Administration, Inhalation , Double-Blind Method , Bronchodilator Agents/therapeutic use , Acute Disease
5.
Mymensingh Med J ; 31(1): 208-215, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34999704

ABSTRACT

Delay in seeking medical care of the patients with acute myocardial infarction (AMI) could affect the outcome. Therefore, it is important to recognize and reduce pre-hospital in initiating treatment of these patients. The objective of the study was to evaluate the factors associated with delayed hospital arrival of patients with AMI. This cross-sectional study was carried out among 385 patients with AMI attended in the Department of Cardiology, Dhaka Medical College Hospital (DMCH), Dhaka, Bangladesh. The delay in arrival to the hospital was recorded along with socio-demographic data, conditions of the patients during onset and other relevant data. The mean age of the patients 59.7±9.9 years with a male-female ratio of 2.4:1. About 22% of patients with AMI arrived at the hospital within 6 hours of symptoms onset and only around 13% arrived within 2 hours of onset of symptoms. Comparatively younger (p=0.037), unmarried (p=0.008) and Muslim (p=0.008) patients were more likely to present for hospital care sooner (p=0.037). Patients coming from upper middle class of socioeconomic status (p<0.001) and those with college or post college level of education (p<0.001) were more likely to present earlier for hospital care. Prehospital delay was larger in non-manual worker patients (p<0.001) as well as in patients with onset of chest pain during rest period (p<0.001) and while at home (p<0.001). Pre-hospital delay was shorter in patients with onset of chest pain from 12am to 6am and 6am to 12pm (p<0.001). Lack of awareness of AMI symptoms and benefits of its early treatment, long distance and mode of transport were shown as the most common causes of delayed arrival of patients at hospital (p<0.001). This study has identified the factors associated with AMI in context of Bangladesh. Effective measures including increasing awareness of AMI symptoms should be taken for better outcome of the patients.


Subject(s)
Myocardial Infarction , Aged , Bangladesh/epidemiology , Cross-Sectional Studies , Female , Hospitals , Humans , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Myocardial Infarction/therapy , Time Factors
6.
Bone Marrow Transplant ; 55(10): 2026-2034, 2020 10.
Article in English | MEDLINE | ID: mdl-32286505

ABSTRACT

In 2010, we reported the outcome of hematopoietic stem cell transplantation (HSCT) in 11 children with Griscelli syndrome type 2 (GS2). We report here the update on this cohort to include 35 patients. Twenty-seven (77%) patients received conditioning regimen including busulfan, cyclophosphamide with etoposide. Eight (23%) were given busulfan, fludarabine. Thiotepa was added to busulfan and fludarabine regimen in two patients; one received haploidentical marrow and one unrelated cord blood. Posttransplant clinical events included veno-occlusive disease (n = 7), acute (n = 8), or chronic (n = 1) graft-versus-host disease II-IV. With a mortality rate of 37.1% (n = 13) and a median follow-up of 87.7 months of the survivors, 5-year cumulative probability of overall survival (OS) for our cohort of patients was 62.7% (±8.2%). Cumulative probability of 5-year OS was significantly better in those who did not have hemophagocytic lymphohistiocytosis (HLH) prior to HSCT (100% vs. 53.3 ± 9.5%, P value: 0.042). Of the 16 patients with neurologic involvement before HSCT, 8 survived and 3 presented sequelae. OS at 5-year was 50 ± 12.5% and 73.3 ± 10.2% (P value: 0.320) in patients with and without CNS involvement, respectively. In conclusion, HSCT in patients with GS2 is potentially curative with long-term disease-free survival. Early HSCT before the development of the accelerated phase is associated with a better outcome.


Subject(s)
Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Lymphohistiocytosis, Hemophagocytic , Piebaldism , Primary Immunodeficiency Diseases , Busulfan , Child , Humans , Lymphohistiocytosis, Hemophagocytic/therapy , Neoplasm Recurrence, Local , Piebaldism/therapy , Primary Immunodeficiency Diseases/therapy , Retrospective Studies , Transplantation Conditioning , Vidarabine
7.
Indian J Cancer ; 54(1): 236-240, 2017.
Article in English | MEDLINE | ID: mdl-29199698

ABSTRACT

BACKGROUND: Surgical treatment for lung cancer has evolved from pneumonectomy to lobectomy/sleeve resection around the world. Although condemned for poor outcomes, pneumonectomy may still be required in a select group of patients in developing countries. With the better patient selection, optimization of medical comorbidities, better perioperative care; pneumonectomy may show better results. Thus, there is a need to reconsider the role of pneumonectomy in patients with locally advanced lung cancer in the current scenario. PATIENTS AND METHODS: The aim of this study was to analyze the demographic and clinicopathologic profile of lung cancer patients and the role of pneumonectomy at a tertiary cancer center in India. The records of patients, who underwent surgery for lung cancer at our institute from January 2011 to April 2014, were analyzed retrospectively, and various parameters in pneumonectomy were compared to lobectomy patients. RESULTS: Out of 48 patients undergoing major lung resections, nearly 80% patients were symptomatic at presentation and were mostly in advanced stages, thus requiring neoadjuvant chemotherapy in 45.8% cases and pneumonectomy in 41.6% patients. There was no difference in morbidity and mortality in pneumonectomy (25%, 5%) versus lobectomy (21.2%, 3.5%). Disease-free survival at 1, 2, and 3 years after pneumonectomy (71.8%, 51.4%, and 42.8%) was comparable to lobectomy (73.3%, 66.1%, and 55.6%). After neoadjuvant therapy, survival was not affected by the type of surgery. CONCLUSIONS: In the Indian scenario, as the majority of lung cancer patients present at an advanced stage, pneumonectomy still plays a major role, and the acceptable postoperative outcome can be achieved with aggressive perioperative management.


Subject(s)
Lung Neoplasms/epidemiology , Lung Neoplasms/surgery , Pneumonectomy , Adolescent , Adult , Aged , Female , Humans , India/epidemiology , Lung Neoplasms/pathology , Lung Neoplasms/therapy , Male , Middle Aged , Neoadjuvant Therapy , Neoplasm Staging , Retrospective Studies , Tertiary Healthcare , Young Adult
9.
Sci Rep ; 6: 24278, 2016 Apr 07.
Article in English | MEDLINE | ID: mdl-27052690

ABSTRACT

Cold environments dominate the Earth's biosphere and the resident microorganisms play critical roles in fulfilling global biogeochemical cycles. However, only few studies have examined the molecular basis of thermosensing; an ability that microorganisms must possess in order to respond to environmental temperature and regulate cellular processes. Two component regulatory systems have been inferred to function in thermal regulation of gene expression, but biochemical studies assessing these systems in Bacteria are rare, and none have been performed in Archaea or psychrophiles. Here we examined the LtrK/LtrR two component regulatory system from the Antarctic archaeon, Methanococcoides burtonii, assessing kinase and phosphatase activities of wild-type and mutant proteins. LtrK was thermally unstable and had optimal phosphorylation activity at 10 °C (the lowest optimum activity for any psychrophilic enzyme), high activity at 0 °C and was rapidly thermally inactivated at 30 °C. These biochemical properties match well with normal environmental temperatures of M. burtonii (0-4 °C) and the temperature this psychrophile is capable of growing at in the laboratory (-2 to 28 °C). Our findings are consistent with a role for LtrK in performing phosphotransfer reactions with LtrR that could lead to temperature-dependent gene regulation.


Subject(s)
Adaptation, Physiological/genetics , Archaeal Proteins/genetics , Cold Temperature , Methanosarcinaceae/genetics , Amino Acid Sequence , Antarctic Regions , Archaeal Proteins/chemistry , Archaeal Proteins/metabolism , Calorimetry, Differential Scanning , Cloning, Molecular , Computer Simulation , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation, Archaeal , Methanosarcinaceae/metabolism , Models, Molecular , Mutation , Phosphoric Monoester Hydrolases/chemistry , Phosphoric Monoester Hydrolases/genetics , Phosphoric Monoester Hydrolases/metabolism , Phosphorylation , Phosphotransferases/chemistry , Phosphotransferases/genetics , Phosphotransferases/metabolism , Protein Domains , Protein Stability , Sequence Homology, Amino Acid
10.
Environ Microbiol ; 18(9): 2810-24, 2016 09.
Article in English | MEDLINE | ID: mdl-26769275

ABSTRACT

TRAM domain proteins present in Archaea and Bacteria have a ß-barrel shape with anti-parallel ß-sheets that form a nucleic acid binding surface; a structure also present in cold shock proteins (Csps). Aside from protein structures, experimental data defining the function of TRAM domains is lacking. Here, we explore the possible functional properties of a single TRAM domain protein, Ctr3 (cold-responsive TRAM domain protein 3) from the Antarctic archaeon Methanococcoides burtonii that has increased abundance during low temperature growth. Ribonucleic acid (RNA) bound by Ctr3 in vitro was determined using RNA-seq. Ctr3-bound M. burtonii RNA with a preference for transfer (t)RNA and 5S ribosomal RNA, and a potential binding motif was identified. In tRNA, the motif represented the C loop; a region that is conserved in tRNA from all domains of life and appears to be solvent exposed, potentially providing access for Ctr3 to bind. Ctr3 and Csps are structurally similar and are both inferred to function in low temperature translation. The broad representation of single TRAM domain proteins within Archaea compared with their apparent absence in Bacteria, and scarcity of Csps in Archaea but prevalence in Bacteria, suggests they represent distinct evolutionary lineages of functionally equivalent RNA-binding proteins.


Subject(s)
Archaeal Proteins/chemistry , Methanosarcinaceae/genetics , RNA, Archaeal/chemistry , RNA-Binding Proteins/chemistry , Antarctic Regions , Archaeal Proteins/genetics , Archaeal Proteins/metabolism , Cold Temperature , RNA, Archaeal/metabolism , RNA, Ribosomal, 5S/chemistry , RNA, Ribosomal, 5S/metabolism , RNA, Transfer/chemistry , RNA, Transfer/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism
11.
Clin Exp Immunol ; 181(2): 286-96, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25845290

ABSTRACT

Bacillus Calmette-Guérin (BCG) remains the only available and most widely administered vaccine against Mycobacterium tuberculosis (Mtb), yet it fails to protect vaccinated individuals either from primary infection or reactivation of latent tuberculosis (TB). Despite BCG's variable efficacy against TB, the fact remains that BCG imparts protection in children against the disease, indicating that BCG possesses a wide protective antigenic repertoire. However, its failure to impart protection in adulthood can be linked to its failure to generate long-lived memory response and elicitation of an inadequate immune response against latency-associated antigens. Therefore, to improve the protective efficacy of BCG, a novel vaccination strategy is required. Consequently, in the present study, we have exploited the vaccination potential of liposomized α-crystalline 1 (Acr1L), a latency-associated antigen to induce enduring protective immunity against Mtb in BCG-primed animals. It is noteworthy that an increase in the multi-functional [interferon (IFN)-γ(hi) /tumour necrosis factor (TNF)-α(hi) ] CD4 and CD8 T cells were observed in BCG-primed and Acr1L-boosted (BCG-Acr1L) animals, compared to BCG alone. Further, substantial expansion of both central memory (CD44(hi) /CD62L(hi) ) and effector memory (CD44(hi) /CD62L(lo) ) populations of CD4 and CD8 T cells was noted. Importantly, BCG-Acr1L exhibited significantly better protection than BCG, as evidenced by a reduction in the bacterial burden and histopathological data of the lungs. In essence, BCG-Acr1L could be a potent future vaccination strategy to reinvigorate BCG potency.


Subject(s)
BCG Vaccine/immunology , Bacterial Proteins/immunology , Immunization, Secondary , Latent Tuberculosis/prevention & control , Mycobacterium tuberculosis/drug effects , alpha-Crystallins/immunology , Animals , BCG Vaccine/administration & dosage , BCG Vaccine/genetics , Bacterial Load/drug effects , Bacterial Proteins/genetics , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/microbiology , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/microbiology , CD8-Positive T-Lymphocytes/pathology , Female , Hyaluronan Receptors/genetics , Hyaluronan Receptors/immunology , Immunologic Memory/drug effects , Immunophenotyping , Interferon-gamma/biosynthesis , Interferon-gamma/immunology , L-Selectin/genetics , L-Selectin/immunology , Latent Tuberculosis/immunology , Latent Tuberculosis/microbiology , Latent Tuberculosis/pathology , Liposomes/chemistry , Liposomes/immunology , Lung/drug effects , Lung/immunology , Lung/microbiology , Lung/pathology , Mice , Mycobacterium bovis/chemistry , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/immunology , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/immunology , alpha-Crystallins/genetics
12.
Indian J Pharmacol ; 47(1): 72-9, 2015.
Article in English | MEDLINE | ID: mdl-25821315

ABSTRACT

BACKGROUND: Qurse-e-istisqua (Q-e-I), an Unani medicine commonly prescribed to treat liver disorders. OBJECTIVES: To study efficacy and safety of Q-e-I in hepatitis C virus (HCV) infection. METHODS: In this randomized double-blind exploratory study, 60 naive patients of HCV infection were assigned to receive either interferonα2a (IFNα2a) (3 mIU, subcutaneous, thrice weekly), ribavirin (RBV) (1000 mg, orally, twice daily in divided doses) and placebo (n = 30) or IFNα2a, RBV and Q-e-I (5 g, orally, thrice daily in divided doses) (n = 30). HCV RNA levels, serum hyaluronic acid (SHA), ultrasound image scoring for fibrosis, liver and renal function test, prothrombin time, were done at the baseline and thereafter periodically. RESULTS: Early virologic response (EVR), end of treatment response (ETR) and sustained virologic response (SVR) were 90%, 96.6% and 90% in the control group and 86.6%, 90.0% and 83.3% in the treatment group. SHA level was lower in the treatment group at the end of the treatment as compared to the control group. Mean end of follow-up ultrasound image scoring for fibrosis in the control and the treatment group was 1.37 ± 0.07 and 1.22 ± 0.06 respectively. Aspartate aminotransferase (AST) levels were significantly lower in the treatment group than the control group at 1-month. Commonly observed adverse drug reactions included fever, hair fall, fatigue, anemia, and diarrhea. CONCLUSION: Q-e-I was well tolerated and showed anti-fibrotic activity. EVR, ETR and SVR suggested that Q-e-I do not have any anti-HCV activity. Early recovery in AST and inhibition of progress of fibrosis in Q-e-I group was probably due to the anti-inflammatory and antioxidant activity of its ingredients.


Subject(s)
Antiviral Agents/therapeutic use , Hepatitis C, Chronic/drug therapy , Plant Extracts/therapeutic use , Plant Preparations/therapeutic use , Adult , Antiviral Agents/adverse effects , Aspartate Aminotransferases/blood , Biomarkers/blood , Blood Coagulation/drug effects , Blood Coagulation Tests , Double-Blind Method , Drug Therapy, Combination , Female , Hepacivirus/drug effects , Hepacivirus/genetics , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/virology , Humans , Hyaluronic Acid/blood , India , Interferon alpha-2 , Interferon-alpha/therapeutic use , Liver Cirrhosis/diagnosis , Liver Cirrhosis/drug therapy , Liver Cirrhosis/virology , Liver Function Tests , Male , Plant Extracts/adverse effects , Plant Preparations/adverse effects , Prospective Studies , RNA, Viral/blood , Recombinant Proteins/therapeutic use , Ribavirin/therapeutic use , Time Factors , Treatment Outcome , Viral Load
13.
J Oncol Pharm Pract ; 21(5): 339-47, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24821691

ABSTRACT

INTRODUCTION: Numerous international organisations have advocated the preparation of vincristine in small volume intravenous bags in order to eliminate inadvertent intrathecal administration. However, the risk of extravasation is a significant deterrent, and adoption of this practice has been variable and only hesitantly accepted in the clinical setting. PURPOSE: We carried out a study with the aims of establishing the incidence of reported extravasation of vincristine administration to paediatric and adult patients in mini-bags; here we describe motivating factors and barriers faced by clinical staff. The secondary aim was to support the need for change and implementation of the international recommendations. METHODS: Chemotherapy-certified nurses completed a survey spanning August 2009 to August 2011, to ascertain the incidence of extravasation associated with the administration of vincristine in mini-bags. RESULTS: This period captured 421 occasions of vincristine administration in 25-ml or 50-ml mini-bags (in 0.9% sodium chloride). The median age of patients was 13 years (range 2.5 months to 99 years). Vincristine was administered through peripheral lines (26.4%), portacath (52.0%), PICC line (15.9%) and Hickman line (5.7%). The majority of infusions were over at least 10 minutes (50.1%). There were no cases of extravasation reported. CONCLUSIONS: The administration of vincristine in small volume intravenous bags was safe, practical, and feasible in all patient groups. The successful implementation of the international recommendations for vincristine administration in mini-bags to eliminate potential inadvertent intrathecal administration was dependent on stakeholder buy-in.


Subject(s)
Antineoplastic Agents, Phytogenic/administration & dosage , Drug Packaging , Extravasation of Diagnostic and Therapeutic Materials/epidemiology , Vincristine/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , Antineoplastic Agents, Phytogenic/adverse effects , Child , Child, Preschool , Female , Humans , Infant , Infusions, Intravenous , Male , Medication Errors/prevention & control , Middle Aged , Prospective Studies , Vincristine/adverse effects , Young Adult
14.
Med Image Anal ; 17(8): 1293-303, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23410511

ABSTRACT

This paper proposes a new algorithm for the efficient, automatic detection and localization of multiple anatomical structures within three-dimensional computed tomography (CT) scans. Applications include selective retrieval of patients images from PACS systems, semantic visual navigation and tracking radiation dose over time. The main contribution of this work is a new, continuous parametrization of the anatomy localization problem, which allows it to be addressed effectively by multi-class random regression forests. Regression forests are similar to the more popular classification forests, but trained to predict continuous, multi-variate outputs, where the training focuses on maximizing the confidence of output predictions. A single pass of our probabilistic algorithm enables the direct mapping from voxels to organ location and size. Quantitative validation is performed on a database of 400 highly variable CT scans. We show that the proposed method is more accurate and robust than techniques based on efficient multi-atlas registration and template-based nearest-neighbor detection. Due to the simplicity of the regressor's context-rich visual features and the algorithm's parallelism, these results are achieved in typical run-times of only ∼4 s on a conventional single-core machine.


Subject(s)
Algorithms , Data Interpretation, Statistical , Image Interpretation, Computer-Assisted/methods , Pattern Recognition, Automated/methods , Regression Analysis , Tomography, X-Ray Computed/methods , Whole Body Imaging/methods , Humans , Radiation Dosage , Radiation Protection/methods , Radiometry/methods , Reproducibility of Results , Sensitivity and Specificity
15.
Microb Biotechnol ; 4(4): 449-60, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21733127

ABSTRACT

The bulk of the Earth's biosphere is cold (e.g. 90% of the ocean's waters are ≤ 5°C), sustaining a broad diversity of microbial life. The permanently cold environments vary from the deep ocean to alpine reaches and to polar regions. Commensurate with the extent and diversity of the ecosystems that harbour psychrophilic life, the functional capacity of the microorganisms that inhabitat the cold biosphere are equally diverse. As a result, indigenous psychrophilic microorganisms provide an enormous natural resource of enzymes that function effectively in the cold, and these cold-adapted enzymes have been targeted for their biotechnological potential. In this review we describe the main properties of enzymes from psychrophiles and describe some of their known biotechnological applications and ways to potentially improve their value for biotechnology. The review also covers the use of metagenomics for enzyme screening, the development of psychrophilic gene expression systems and the use of enzymes for cleaning.


Subject(s)
Biotechnology/methods , Environmental Microbiology , Enzymes/metabolism , Enzymes/radiation effects , Cold Temperature , Enzymes/isolation & purification
16.
Indian Heart J ; 62(1): 17-20, 2010.
Article in English | MEDLINE | ID: mdl-21180029

ABSTRACT

OBJECTIVE: To evaluate the immediate results of balloon mitral valvulplasty in mitral restenosis patients with previous surgical mitral commissurotomy. METHODS: Percuteneous balloon mitral valvuloplasty (BMV) was done in 145 cases of which 70patients had the history of previous surgical commissurotomy (Group I) and 75 patients were the new cases for the BMV (Group II). RESULTS: In group I the age range was 35-65 years. In group I the duration of surgical commissurotomy (SC) was of 2-18 years past. In this group the result of balloon mitral valvuloplasty (BMV) was successful in 69 cases. Mitral valve area (MVA) before the procedure was 0.5-0.9 sq cm with mean 0.7 +/- 0.2 sq cm. Following procedure the MVA was 1.2-2.0 cm2 with a mean of 1.6 +/- 0.4 cm2. Mean gradient across mitral valve (MV) before the procedure was 15-25 mm of Hg with a mean 20 +/- 5 mm of Hg and after the procedure was 3-5 mm Hg with a mean of 4 +/- 1 mm Hg. In Group I, MVA > 1.8 cm2 was achieved in 25 cases & > 1.2-1.8 cm2 in 44 cases. Mitral regurgitation > or = grade 1 occurred in 8 cases (compared to previous echocardiography). In group II the age range was between 35-60 years. The result of BMV was successful in 74 cases. MVA before the procedure was 0.4-1.2 cm2 with a mean of 0.8 +/- 0.4 cm2. Following the procedure MVA was 1.3-2.1 cm2 with a mean of 1.7 +/- 0.4 cm2. Mean gradient across the mitral valve before the procedure was 15-29 mm of Hg with a mean of 22 +/- 7 mm of Hg. Mean gradient across the mitral valve after the procedure was 2-4 mm of Hg with a mean of 3 +/- 1 mm of Hg. MVA more than 1.8 cm2 was achieved in 29 cases and between 1.3-1.8 in 45 cases. CONCLUSION: BMVin patients with mitral restenosis following Surgical mitral commissurtomy can be performed with almost similar success rate like that of BMV for the first time with low risk of major cardiac complication.


Subject(s)
Catheterization , Mitral Valve Stenosis/therapy , Adult , Catheterization/methods , Echocardiography , Female , Humans , Male , Middle Aged , Mitral Valve Stenosis/diagnostic imaging , Treatment Outcome
17.
J Hosp Infect ; 74(1): 22-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19914736

ABSTRACT

Research has shown that healthcare workers' clothes can become contaminated with pathogens. This study aimed to determine whether hospital doctors can change their attire to reduce the possibility of cross-infection without jeopardising the doctor-patient relationship. In this experimental repeated-measures study, 55 male and 45 female inpatients (mean age: 52.89 years) were randomly selected. Participants were shown photographs of medical dresscodes and asked to rate their appropriateness on a 5-point Likert scale. They were then read a standardised statement regarding the significance of attire to cross-infection and the exercise was repeated. Pre statement, there was no significant difference between the majority of dress options, though casual dress (male and female) and short-sleeved top (female) were considered significantly less appropriate. Post statement, surgical 'scrubs' and short-sleeved top/shirt were deemed most appropriate (P<0.0001). There was no significant difference between short-sleeved shirt and scrubs for males. For females, scrubs were preferred (P=0.0005). Participants expressed no significant preference for medical attire, with the exception of a dislike of casual dress. However, once informed of the significance of attire to cross-infection, preference changes to favour dresscodes which may minimise infection risk.


Subject(s)
Clothing/psychology , Clothing/standards , Cross Infection/prevention & control , Infection Control/methods , Physician-Patient Relations , Female , Humans , Inpatients , Male , Middle Aged
18.
Mucosal Immunol ; 1 Suppl 1: S34-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19079226

ABSTRACT

There is evidence that Foxp3(+) regulatory T (T(R)) cells contribute to intestinal homeostasis and that deficiencies in this population can lead to chronic intestinal inflammation. Here, we review recent studies that demonstrate that the gut is a site of peripheral generation of T(R) cells. Functionally specialized gut dendritic cell populations promote T(R) cells through a transforming growth factor-beta and retinoic acid-dependent mechanism. Gut-driven T(R) cells may represent a tissue-specific mechanism to broaden the repertoire of T(R) cells focussed on the gut.


Subject(s)
Antigens, CD/immunology , Dendritic Cells/immunology , Forkhead Transcription Factors/immunology , Integrin alpha Chains/immunology , Intestines/immunology , Lymphoid Tissue/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Humans
19.
J Endocrinol Invest ; 31(10): 893-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19092295

ABSTRACT

Genetic polymorphisms of DNA repair genes seem to determine the DNA repair capacity. We hypothesized that polymorphisms of genes responsible for DNA repair may be associated with risk of thyroid cancer. To evaluate the role of genetic polymorphisms of DNA repair genes in thyroid cancer, we conducted a hospital-based case-control study in Saudi population. Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN. RAD52 GLN221GLU genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing thyroid cancer compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58]. Similarly, RAD52 2259 genotypes CT and variant allele T showed a significant difference in terms of risk estimation (CT vs CC; p<0.05, OR=1.53, 95% CI=1.03-2.28, CT+TT vs CC; p<0.001, OR=1.922, 95% CI=1.31-2.82). Remaining loci demonstrated no significance with risk. Of the 21 loci screened, RAD52 2259 and RAD52 GLN221GLU may be of importance to disease process and may be associated with papillary thyroid cancer risk in Saudi Arabian population.


Subject(s)
Carcinoma, Papillary/genetics , DNA Repair/genetics , Genetic Predisposition to Disease/genetics , Rad52 DNA Repair and Recombination Protein/genetics , Thyroid Neoplasms/genetics , Arabs/genetics , Humans , Polymorphism, Restriction Fragment Length , Polymorphism, Single Nucleotide , Saudi Arabia , Thyroid Neoplasms/etiology
20.
Ir J Med Sci ; 177(1): 39-42, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18172575

ABSTRACT

OBJECTIVE: Assess the suitability of SPARC sling as a minimally invasive operation for female stress urinary incontinence. MATERIALS AND METHODS: One hundred consecutive patients were evaluated over 45-month period. All had stress urinary incontinence (SUI), proven on urodynamics and cough stress test, independently or combined with urge incontinence but with predominantly SUI. King's Health Questionnaire 1993 (KHQ) and SF36 Health Survey forms were completed pre and post operatively. Peri-operative features, complications and results were recorded. RESULTS: Mean follow-up was 20 months. SUI was cured or significantly reduced in 88% of cases. Role Limitations and Severity Measures (as per KHQ) were considerably reduced. Post-op retention in 11% cases resolved spontaneously within 2 weeks. One case had readjustment of sling. Complications were small in number and minor in nature. CONCLUSION: SPARC sling is highly effective with low complication rates. It is an alternative to tension free vaginal tape.


Subject(s)
Minimally Invasive Surgical Procedures/instrumentation , Prosthesis Implantation/instrumentation , Suburethral Slings , Urinary Incontinence, Stress/surgery , Urologic Surgical Procedures/instrumentation , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Middle Aged , Minimally Invasive Surgical Procedures/adverse effects , Minimally Invasive Surgical Procedures/methods , Population Surveillance , Postoperative Complications , Prospective Studies , Prosthesis Implantation/adverse effects , Prosthesis Implantation/methods , Severity of Illness Index , Treatment Outcome , Urinary Incontinence, Stress/diagnosis , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...